Comparative genomics of the neglected human malaria parasite Plasmodium vivax JM Carlton, JH Adams, JC Silva, SL Bidwell, H Lorenzi, E Caler, ... Nature 455 (7214), 757-763, 2008 | 1004 | 2008 |
A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests D Gamboa, MF Ho, J Bendezu, K Torres, PL Chiodini, JW Barnwell, ... PloS one 5 (1), e8091, 2010 | 554 | 2010 |
Mutations in Plasmodium falciparumCytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site M Korsinczky, N Chen, B Kotecka, A Saul, K Rieckmann, Q Cheng Antimicrobial agents and chemotherapy 44 (8), 2100-2108, 2000 | 480 | 2000 |
A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province … I Harris, WW Sharrock, LM Bain, KA Gray, A Bobogare, L Boaz, K Lilley, ... Malaria journal 9, 1-8, 2010 | 362 | 2010 |
Genetic Diversity of Plasmodium falciparum Histidine-Rich Protein 2 (PfHRP2) and Its Effect on the Performance of PfHRP2-Based Rapid Diagnostic Tests J Baker, J McCarthy, M Gatton, DE Kyle, V Belizario, J Luchavez, D Bell, ... The Journal of infectious diseases 192 (5), 870-877, 2005 | 361 | 2005 |
stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens Q Cheng, N Cloonan, K Fischer, J Thompson, G Waine, M Lanzer, A Saul Molecular and biochemical parasitology 97 (1-2), 161-176, 1998 | 333 | 1998 |
Artemisinin-Induced Dormancy in Plasmodium falciparum: Duration, Recovery Rates, and Implications in Treatment Failure F Teuscher, ML Gatton, N Chen, J Peters, DE Kyle, Q Cheng The Journal of infectious diseases 202 (9), 1362-1368, 2010 | 289 | 2010 |
Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms R Suwanarusk, B Russell, M Chavchich, F Chalfein, E Kenangalem, ... PloS one 2 (10), e1089, 2007 | 263 | 2007 |
Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting Q Cheng, ML Gatton, J Barnwell, P Chiodini, J McCarthy, D Bell, ... Malaria journal 13, 1-8, 2014 | 234 | 2014 |
Effect of Sequence Variation in Plasmodium falciparum Histidine- Rich Protein 2 on Binding of Specific Monoclonal Antibodies: Implications for Rapid Diagnostic … N Lee, J Baker, KT Andrews, ML Gatton, D Bell, Q Cheng, J McCarthy Journal of clinical microbiology 44 (8), 2773-2778, 2006 | 225 | 2006 |
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests J Baker, MF Ho, A Pelecanos, M Gatton, N Chen, S Abdullah, A Albertini, ... | 210 | 2010 |
Plasmodium knowlesi in human, Indonesian Borneo M Figtree, R Lee, L Bain, T Kennedy, S Mackertich, M Urban, Q Cheng, ... Emerging infectious diseases 16 (4), 672, 2010 | 207 | 2010 |
MEASUREMENT OF PLASMODJUM FALCIPARUAM GROVVTH RATES IN VIVO: A TEST OF MALARIA VACCINES Q Cheng, G Lawrence, C Reed, A Stowers, L Ranford-Cartwright Am. J. Trop. Med. Hyg 57 (4), 495-500, 1997 | 201 | 1997 |
Relapses of Plasmodium vivax Infection Result from Clonal Hypnozoites Activated at Predetermined Intervals N Chen, A Auliff, K Rieckmann, Q Cheng The Journal of infectious diseases 195 (7), 934-941, 2007 | 196 | 2007 |
Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea A Berhane, K Anderson, S Mihreteab, K Gresty, E Rogier, S Mohamed, ... Emerging infectious diseases 24 (3), 462, 2018 | 192 | 2018 |
Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax B Russell, F Chalfein, B Prasetyorini, E Kenangalem, K Piera, ... Antimicrobial agents and chemotherapy 52 (3), 1040-1045, 2008 | 173 | 2008 |
Systematic Review of Sub-microscopic P. vivax Infections: Prevalence and Determining Factors Q Cheng, J Cunningham, ML Gatton PLoS neglected tropical diseases 9 (1), e3413, 2015 | 171 | 2015 |
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests GJ Domingo, AW Satyagraha, A Anvikar, K Baird, G Bancone, P Bansil, ... Malaria journal 12, 1-12, 2013 | 170 | 2013 |
Amplification of pvmdr1 Associated with Multidrug-Resistant Plasmodium vivax R Suwanarusk, M Chavchich, B Russell, A Jaidee, F Chalfein, M Barends, ... The Journal of infectious diseases 198 (10), 1558-1564, 2008 | 167 | 2008 |
Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers G Lawrence, Q Cheng, C Reed, D Taylor, A Stowers, N Cloonan, ... Vaccine 18 (18), 1925-1931, 2000 | 162 | 2000 |